EMA to provide guidance on avoiding nitrosamines in medicines
The EMA has announced it is drafting guidance on how to avoid the presence of nitrosamines, a probable carcinogenic ingredient, in drugs.
List view / Grid view
The EMA has announced it is drafting guidance on how to avoid the presence of nitrosamines, a probable carcinogenic ingredient, in drugs.
The seven centres will aid disease research and clinical development, improving access to patient data for studies.
A team has developed a microrobot that is effective at targeting specific areas, so could be used in hyperthermia therapies when treating cancers.
A ban on Indian trade to Pakistan has been partly changed to allow the import of drugs after a shortage of critical medicine.
Mahfoozur Rahman and Sarwar Beg explain why we need to change tack from traditional formulation-driven development to a target-based approach in order to increase success with anticancer nanomedicine in the clinic.
The cancer therapeutic, Rozlytrek, has gained FDA approval as well as Priority Review, Breakthrough Therapy and Orphan Drug Designations.
Researchers have developed silica spheres to contain cancer therapeutics that melt at certain temperatures and have the potential to improve drug delivery.
The Middle Eastern country has a limited supply of vital medication needed for conditions such as cancer due to US trade blocks.
FDA issues warning to a company that claimed its CBD products can be used to treat cancer and Alzheimer's disease.
A new drug delivery system disguises chemo-therapeutics as fat in order to destroy tumours.
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
The CMA accuses four pharmaceutical firms of colluding to illegally inflate prices of an anti-nausea drug.
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial...